Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome

Clin Biochem. 2009 Jun;42(9):828-34. doi: 10.1016/j.clinbiochem.2009.01.011. Epub 2009 Feb 4.

Abstract

Objectives: To describe the presence and time-related pattern of circulating pregnancy associated plasma protein A (PAPP-A) levels in patients with non ST-segment elevation acute coronary syndrome (NSTE-ACS).

Design and methods: Consecutively admitted patients (N=573) with clinical signs of NSTE-ACS were included. Blood samples for analysis of PAPP-A were drawn at admission and every 6-8 h until levels of biomarkers of myocardial necrosis showed a consistent decrease.

Results: High-risk NSTE-ACS was diagnosed in 123 patients (23%). Significantly more patients with high-risk NSTE-ACS (63%) had detectable PAPP-A than did those with low-risk NSTE-ACS (49%) (P<0.001). PAPP-A concentrations were significantly associated with typical angina at admission, significant ST-depressions on the ECG, multivessel disease and presence of high-risk NSTE-ACS.

Conclusion: PAPP-A seems to be a marker ischaemia both in patients with low- and high-risk NSTE-ACS, possibly due to the release of PAPP-A from the vulnerable plaque.

MeSH terms

  • Acute Coronary Syndrome / blood*
  • Adult
  • Aged
  • Aged, 80 and over
  • Electrocardiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pregnancy-Associated Plasma Protein-A* / metabolism
  • Young Adult

Substances

  • Pregnancy-Associated Plasma Protein-A